The TED website is eForms-ready since 2.11.2022. The search changed: please adapt your predefined expert queries. Discover the changes in the site news and in the updated Help Pages.

Supplies - 441715-2022
12/08/2022    S155

Germany-Hamburg: Pharmaceutical products

2022/S 155-441715

Contract award notice

Results of the procurement procedure

Supplies

Legal Basis:
Directive 2014/24/EU

Section I: Contracting authority

I.1)Name and addresses
Official name: PBMG eG
Postal address: Ackermannstraße 34
Town: Hamburg
NUTS code: DE Deutschland
Postal code: 22087
Country: Germany
E-mail: pbmg@pbmg.org
Telephone: +49 4046774022
Fax: +49 4046774022
Internet address(es):
Main address: https://www.pbmg.eu
I.4)Type of the contracting authority
Other type: Krankenhäuser
I.5)Main activity
Health

Section II: Object

II.1)Scope of the procurement
II.1.1)Title:

Lieferung Arzneimittel

Reference number: 043-00045 (3555)
II.1.2)Main CPV code
33600000 Pharmaceutical products
II.1.3)Type of contract
Supplies
II.1.4)Short description:

Lieferung Arzneimittel

II.1.6)Information about lots
This contract is divided into lots: yes
II.1.7)Total value of the procurement (excluding VAT)
Value excluding VAT: 1.00 EUR
II.2)Description
II.2.1)Title:
Lot No: 1
II.2.2)Additional CPV code(s)
33600000 Pharmaceutical products
II.2.3)Place of performance
NUTS code: DE Deutschland
II.2.4)Description of the procurement:

Beschaffung von Arzneimitteln: Everolimus, peroral (ATC-Codes L01EG02, L04AA18)

II.2.5)Award criteria
Quality criterion - Name: Alternativlos (einziges Angebot) / Weighting: 1
Cost criterion - Name: Preis nach Abzug aller Vergünstigungen und zuzüglich Lieferkosten / Weighting: 10
II.2.11)Information about options
Options: no
II.2.13)Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds: no
II.2.14)Additional information
II.2)Description
II.2.1)Title:
Lot No: 2
II.2.2)Additional CPV code(s)
33600000 Pharmaceutical products
II.2.3)Place of performance
NUTS code: DE Deutschland
II.2.4)Description of the procurement:

Beschaffung von Arzneimitteln: Eltrombopag, peroral (ATC-Code B02BX05)

II.2.5)Award criteria
Quality criterion - Name: Alternativlos (einziges Angebot) / Weighting: 1
Cost criterion - Name: Preis nach Abzug aller Vergünstigungen und zuzüglich Lieferkosten / Weighting: 10
II.2.11)Information about options
Options: no
II.2.13)Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds: no
II.2.14)Additional information
II.2)Description
II.2.1)Title:
Lot No: 3
II.2.2)Additional CPV code(s)
33600000 Pharmaceutical products
II.2.3)Place of performance
NUTS code: DE Deutschland
II.2.4)Description of the procurement:

Beschaffung von Arzneimitteln: Crizanlizumab, invasiv (ATC-Code B06AX01)

II.2.5)Award criteria
Quality criterion - Name: Alternativlos (einziges Angebot) / Weighting: 1
Cost criterion - Name: Preis nach Abzug aller Vergünstigungen und zuzüglich Lieferkosten / Weighting: 10
II.2.11)Information about options
Options: no
II.2.13)Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds: no
II.2.14)Additional information
II.2)Description
II.2.1)Title:
Lot No: 4
II.2.2)Additional CPV code(s)
33600000 Pharmaceutical products
II.2.3)Place of performance
NUTS code: DE Deutschland
II.2.4)Description of the procurement:

Beschaffung von Arzneimitteln: Valsartan und Sacubitril, peroral (ATC-Code C09DX04)

II.2.5)Award criteria
Quality criterion - Name: Packungsgrößen, Anlieferung, Regalsservice, Lagerungsbedingungen,.. / Weighting: 1
Cost criterion - Name: Preis nach Abzug aller Vergünstigungen und zuzüglich Lieferkosten / Weighting: 10
II.2.11)Information about options
Options: no
II.2.13)Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds: no
II.2.14)Additional information
II.2)Description
II.2.1)Title:
Lot No: 5
II.2.2)Additional CPV code(s)
33600000 Pharmaceutical products
II.2.3)Place of performance
NUTS code: DE Deutschland
II.2.4)Description of the procurement:

Beschaffung von Arzneimitteln: Inclisiran, invasiv (ATC-Code C10AX16)

II.2.5)Award criteria
Quality criterion - Name: Alternativlos (einziges Angebot) / Weighting: 1
Cost criterion - Name: Preis nach Abzug aller Vergünstigungen und zuzüglich Lieferkosten / Weighting: 10
II.2.11)Information about options
Options: no
II.2.13)Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds: no
II.2.14)Additional information
II.2)Description
II.2.1)Title:
Lot No: 6
II.2.2)Additional CPV code(s)
33600000 Pharmaceutical products
II.2.3)Place of performance
NUTS code: DE Deutschland
II.2.4)Description of the procurement:

Beschaffung von Arzneimitteln: Nilotinib, peroral (ATC-Code L01EA03)

II.2.5)Award criteria
Quality criterion - Name: Alternativlos (einziges Angebot) / Weighting: 1
Cost criterion - Name: Preis nach Abzug aller Vergünstigungen und zuzüglich Lieferkosten / Weighting: 10
II.2.11)Information about options
Options: no
II.2.13)Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds: no
II.2.14)Additional information
II.2)Description
II.2.1)Title:
Lot No: 7
II.2.2)Additional CPV code(s)
33600000 Pharmaceutical products
II.2.3)Place of performance
NUTS code: DE Deutschland
II.2.4)Description of the procurement:

Beschaffung von Arzneimitteln: Dabrafenib, peroral (ATC-Code L01EC02)

II.2.5)Award criteria
Quality criterion - Name: Alternativlos (einziges Angebot) / Weighting: 1
Cost criterion - Name: Preis nach Abzug aller Vergünstigungen und zuzüglich Lieferkosten / Weighting: 10
II.2.11)Information about options
Options: no
II.2.13)Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds: no
II.2.14)Additional information
II.2)Description
II.2.1)Title:
Lot No: 8
II.2.2)Additional CPV code(s)
33600000 Pharmaceutical products
II.2.3)Place of performance
NUTS code: DE Deutschland
II.2.4)Description of the procurement:

Beschaffung von Arzneimitteln: Ceritinib, peroral (ATC-Code L01ED02)

II.2.5)Award criteria
Quality criterion - Name: Alternativlos (einziges Angebot) / Weighting: 1
Cost criterion - Name: Preis nach Abzug aller Vergünstigungen und zuzüglich Lieferkosten / Weighting: 10
II.2.11)Information about options
Options: no
II.2.13)Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds: no
II.2.14)Additional information
II.2)Description
II.2.1)Title:
Lot No: 9
II.2.2)Additional CPV code(s)
33600000 Pharmaceutical products
II.2.3)Place of performance
NUTS code: DE Deutschland
II.2.4)Description of the procurement:

Beschaffung von Arzneimitteln: Trametinib, peroral (ATC-Code L01EE01)

II.2.5)Award criteria
Quality criterion - Name: Alternativlos (einziges Angebot) / Weighting: 1
Cost criterion - Name: Preis nach Abzug aller Vergünstigungen und zuzüglich Lieferkosten / Weighting: 10
II.2.11)Information about options
Options: no
II.2.13)Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds: no
II.2.14)Additional information
II.2)Description
II.2.1)Title:
Lot No: 10
II.2.2)Additional CPV code(s)
33600000 Pharmaceutical products
II.2.3)Place of performance
NUTS code: DE Deutschland
II.2.4)Description of the procurement:

Beschaffung von Arzneimitteln: Ribociclib, peroral (ATC-Code L01EF02)

II.2.5)Award criteria
Quality criterion - Name: Alternativlos (einziges Angebot) / Weighting: 1
Cost criterion - Name: Preis nach Abzug aller Vergünstigungen und zuzüglich Lieferkosten / Weighting: 10
II.2.11)Information about options
Options: no
II.2.13)Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds: no
II.2.14)Additional information
II.2)Description
II.2.1)Title:
Lot No: 11
II.2.2)Additional CPV code(s)
33600000 Pharmaceutical products
II.2.3)Place of performance
NUTS code: DE Deutschland
II.2.4)Description of the procurement:

Beschaffung von Arzneimitteln: Lapatinib, peroral (ATC-Code L01EH01)

II.2.5)Award criteria
Quality criterion - Name: Alternativlos (einziges Angebot) / Weighting: 1
Cost criterion - Name: Preis nach Abzug aller Vergünstigungen und zuzüglich Lieferkosten / Weighting: 10
II.2.11)Information about options
Options: no
II.2.13)Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds: no
II.2.14)Additional information
II.2)Description
II.2.1)Title:
Lot No: 12
II.2.2)Additional CPV code(s)
33600000 Pharmaceutical products
II.2.3)Place of performance
NUTS code: DE Deutschland
II.2.4)Description of the procurement:

Beschaffung von Arzneimitteln: Ruxolitinib, peroral (ATC-Code L01EJ01)

II.2.5)Award criteria
Quality criterion - Name: Alternativlos (einziges Angebot) / Weighting: 1
Cost criterion - Name: Preis nach Abzug aller Vergünstigungen und zuzüglich Lieferkosten / Weighting: 10
II.2.11)Information about options
Options: no
II.2.13)Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds: no
II.2.14)Additional information
II.2)Description
II.2.1)Title:
Lot No: 13
II.2.2)Additional CPV code(s)
33600000 Pharmaceutical products
II.2.3)Place of performance
NUTS code: DE Deutschland
II.2.4)Description of the procurement:

Beschaffung von Arzneimitteln: Midostaurin, peroral (ATC-Code L01EX10)

II.2.5)Award criteria
Quality criterion - Name: Alternativlos (einziges Angebot) / Weighting: 1
Cost criterion - Name: Preis nach Abzug aller Vergünstigungen und zuzüglich Lieferkosten / Weighting: 10
II.2.11)Information about options
Options: no
II.2.13)Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds: no
II.2.14)Additional information
II.2)Description
II.2.1)Title:
Lot No: 14
II.2.2)Additional CPV code(s)
33600000 Pharmaceutical products
II.2.3)Place of performance
NUTS code: DE Deutschland
II.2.4)Description of the procurement:

Beschaffung von Arzneimitteln: Mycophenolsäure, peroral (ATC-Code L04AA06)

II.2.5)Award criteria
Quality criterion - Name: Alternativlos (einziges Angebot) / Weighting: 1
Cost criterion - Name: Preis nach Abzug aller Vergünstigungen und zuzüglich Lieferkosten / Weighting: 10
II.2.11)Information about options
Options: no
II.2.13)Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds: no
II.2.14)Additional information
II.2)Description
II.2.1)Title:
Lot No: 15
II.2.2)Additional CPV code(s)
33600000 Pharmaceutical products
II.2.3)Place of performance
NUTS code: DE Deutschland
II.2.4)Description of the procurement:

Beschaffung von Arzneimitteln: Basiliximab, invasiv (ATC-Code L04AC02)

II.2.5)Award criteria
Cost criterion - Name: Preis nach Abzug aller Vergünstigungen und zuzüglich Lieferkosten / Weighting: 10
II.2.11)Information about options
Options: no
II.2.13)Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds: no
II.2.14)Additional information
II.2)Description
II.2.1)Title:
Lot No: 16
II.2.2)Additional CPV code(s)
33600000 Pharmaceutical products
II.2.3)Place of performance
NUTS code: DE Deutschland
II.2.4)Description of the procurement:

Beschaffung von Arzneimitteln: Canakinumab, invasiv (ATC-Code L04AC08)

II.2.5)Award criteria
Cost criterion - Name: Preis nach Abzug aller Vergünstigungen und zuzüglich Lieferkosten / Weighting: 10
II.2.11)Information about options
Options: no
II.2.13)Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds: no
II.2.14)Additional information
II.2)Description
II.2.1)Title:
Lot No: 17
II.2.2)Additional CPV code(s)
33600000 Pharmaceutical products
II.2.3)Place of performance
NUTS code: DE Deutschland
II.2.4)Description of the procurement:

Beschaffung von Arzneimitteln: Secukinumab, invasiv (ATC-Code L04AC10)

II.2.5)Award criteria
Quality criterion - Name: Alternativlos (einziges Angebot) / Weighting: 1
Cost criterion - Name: Preis nach Abzug aller Vergünstigungen und zuzüglich Lieferkosten / Weighting: 10
II.2.11)Information about options
Options: no
II.2.13)Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds: no
II.2.14)Additional information
II.2)Description
II.2.1)Title:
Lot No: 18
II.2.2)Additional CPV code(s)
33600000 Pharmaceutical products
II.2.3)Place of performance
NUTS code: DE Deutschland
II.2.4)Description of the procurement:

Beschaffung von Arzneimitteln: Ciclosporin, invasiv (ATC-Code L04AD01)

II.2.5)Award criteria
Cost criterion - Name: Preis nach Abzug aller Vergünstigungen und zuzüglich Lieferkosten / Weighting: 10
II.2.11)Information about options
Options: no
II.2.13)Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds: no
II.2.14)Additional information
II.2)Description
II.2.1)Title:
Lot No: 19
II.2.2)Additional CPV code(s)
33600000 Pharmaceutical products
II.2.3)Place of performance
NUTS code: DE Deutschland
II.2.4)Description of the procurement:

Beschaffung von Arzneimitteln: Ciclosporin, peroral (ATC-Code L04AD01)

II.2.5)Award criteria
Cost criterion - Name: Preis nach Abzug aller Vergünstigungen und zuzüglich Lieferkosten / Weighting: 10
II.2.11)Information about options
Options: no
II.2.13)Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds: no
II.2.14)Additional information
II.2)Description
II.2.1)Title:
Lot No: 20
II.2.2)Additional CPV code(s)
33600000 Pharmaceutical products
II.2.3)Place of performance
NUTS code: DE Deutschland
II.2.4)Description of the procurement:

Beschaffung von Arzneimitteln: Indacaterol und Mometason, bronchopulmonal (ATC-Code R03AK14)

II.2.5)Award criteria
Quality criterion - Name: Alternativlos (einziges Angebot) / Weighting: 1
Cost criterion - Name: Preis nach Abzug aller Vergünstigungen und zuzüglich Lieferkosten / Weighting: 10
II.2.11)Information about options
Options: no
II.2.13)Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds: no
II.2.14)Additional information
II.2)Description
II.2.1)Title:
Lot No: 21
II.2.2)Additional CPV code(s)
33600000 Pharmaceutical products
II.2.3)Place of performance
NUTS code: DE Deutschland
II.2.4)Description of the procurement:

Beschaffung von Arzneimitteln: Indacaterol und Glycopyrroniumbromid, bronchopulmonal (ATC-Code R03AL04)

II.2.5)Award criteria
Quality criterion - Name: Alternativlos (einziges Angebot) / Weighting: 1
Cost criterion - Name: Preis nach Abzug aller Vergünstigungen und zuzüglich Lieferkosten / Weighting: 10
II.2.11)Information about options
Options: no
II.2.13)Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds: no
II.2.14)Additional information
II.2)Description
II.2.1)Title:
Lot No: 22
II.2.2)Additional CPV code(s)
33600000 Pharmaceutical products
II.2.3)Place of performance
NUTS code: DE Deutschland
II.2.4)Description of the procurement:

Beschaffung von Arzneimitteln: Indacaterol, Glycopyrroniumbromid und Mometason, bronchopulmonal (ATC-Code R03AL12)

II.2.5)Award criteria
Quality criterion - Name: Alternativlos (einziges Angebot) / Weighting: 1
Cost criterion - Name: Preis nach Abzug aller Vergünstigungen und zuzüglich Lieferkosten / Weighting: 10
II.2.11)Information about options
Options: no
II.2.13)Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds: no
II.2.14)Additional information
II.2)Description
II.2.1)Title:
Lot No: 23
II.2.2)Additional CPV code(s)
33600000 Pharmaceutical products
II.2.3)Place of performance
NUTS code: DE Deutschland
II.2.4)Description of the procurement:

Beschaffung von Arzneimitteln: Budesonid, bronchopulmonal (ATC-Code R03BA02)

II.2.5)Award criteria
Quality criterion - Name: Alternativlos (einziges Angebot) / Weighting: 1
Cost criterion - Name: Preis nach Abzug aller Vergünstigungen und zuzüglich Lieferkosten / Weighting: 10
II.2.11)Information about options
Options: no
II.2.13)Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds: no
II.2.14)Additional information
II.2)Description
II.2.1)Title:
Lot No: 24
II.2.2)Additional CPV code(s)
33600000 Pharmaceutical products
II.2.3)Place of performance
NUTS code: DE Deutschland
II.2.4)Description of the procurement:

Beschaffung von Arzneimitteln: Glycopyrroniumbromid, bronchopulmonal (ATC-Code R03BB06)

II.2.5)Award criteria
Quality criterion - Name: Alternativlos (einziges Angebot) / Weighting: 1
Cost criterion - Name: Preis nach Abzug aller Vergünstigungen und zuzüglich Lieferkosten / Weighting: 10
II.2.11)Information about options
Options: no
II.2.13)Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds: no
II.2.14)Additional information
II.2)Description
II.2.1)Title:
Lot No: 25
II.2.2)Additional CPV code(s)
33600000 Pharmaceutical products
II.2.3)Place of performance
NUTS code: DE Deutschland
II.2.4)Description of the procurement:

Beschaffung von Arzneimitteln: Omalizumab, invasiv (ATC-Code R03DX05)

II.2.5)Award criteria
Quality criterion - Name: Patentschutz / Weighting: 1
Cost criterion - Name: Preis nach Abzug aller Vergünstigungen und zuzüglich Lieferkosten / Weighting: 10
II.2.11)Information about options
Options: no
II.2.13)Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds: no
II.2.14)Additional information
II.2)Description
II.2.1)Title:
Lot No: 26
II.2.2)Additional CPV code(s)
33600000 Pharmaceutical products
II.2.3)Place of performance
NUTS code: DE Deutschland
II.2.4)Description of the procurement:

Beschaffung von Arzneimitteln: Dexamethason und Antiinfektiva, okulär (ATC-Code S01CA01)

II.2.5)Award criteria
Quality criterion - Name: Alternativlos (einziges Angebot) / Weighting: 1
Cost criterion - Name: Preis nach Abzug aller Vergünstigungen und zuzüglich Lieferkosten / Weighting: 10
II.2.11)Information about options
Options: no
II.2.13)Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds: no
II.2.14)Additional information
II.2)Description
II.2.1)Title:
Lot No: 27
II.2.2)Additional CPV code(s)
33600000 Pharmaceutical products
II.2.3)Place of performance
NUTS code: DE Deutschland
II.2.4)Description of the procurement:

Beschaffung von Arzneimitteln: Timolol, Kombinationen, okulär (ATC-Code S01ED51)

II.2.5)Award criteria
Quality criterion - Name: Alternativlos (einziges Angebot) / Weighting: 1
Cost criterion - Name: Preis nach Abzug aller Vergünstigungen und zuzüglich Lieferkosten / Weighting: 10
II.2.11)Information about options
Options: no
II.2.13)Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds: no
II.2.14)Additional information
II.2)Description
II.2.1)Title:
Lot No: 28
II.2.2)Additional CPV code(s)
33600000 Pharmaceutical products
II.2.3)Place of performance
NUTS code: DE Deutschland
II.2.4)Description of the procurement:

Beschaffung von Arzneimitteln: Brolucizumab, invasiv (ATC-Code S01LA06)

II.2.5)Award criteria
Quality criterion - Name: Alternativlos (einziges Angebot) / Weighting: 1
Cost criterion - Name: Preis nach Abzug aller Vergünstigungen und zuzüglich Lieferkosten / Weighting: 10
II.2.11)Information about options
Options: no
II.2.13)Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds: no
II.2.14)Additional information

Section IV: Procedure

IV.1)Description
IV.1.1)Type of procedure
Competitive procedure with negotiation
IV.1.3)Information about a framework agreement or a dynamic purchasing system
The procurement involves the establishment of a framework agreement
IV.1.8)Information about the Government Procurement Agreement (GPA)
The procurement is covered by the Government Procurement Agreement: no
IV.2)Administrative information
IV.2.1)Previous publication concerning this procedure
Notice number in the OJ S: 2021/S 211-550202
IV.2.8)Information about termination of dynamic purchasing system
IV.2.9)Information about termination of call for competition in the form of a prior information notice

Section V: Award of contract

Contract No: 3555
Title:

043-00045 (3555)

A contract/lot is awarded: yes
V.2)Award of contract
V.2.1)Date of conclusion of the contract:
01/08/2022
V.2.2)Information about tenders
Number of tenders received: 126
Number of tenders received from SMEs: 0
Number of tenders received from tenderers from other EU Member States: 8
Number of tenders received from tenderers from non-EU Member States: 0
Number of tenders received by electronic means: 126
The contract has been awarded to a group of economic operators: no
V.2.3)Name and address of the contractor
Official name: NOVARTIS Pharma GmbH
Postal address: Roonstr. 25
Town: Nürnberg
NUTS code: DE254 Nürnberg, Kreisfreie Stadt
Country: Germany
The contractor is an SME: no
V.2.4)Information on value of the contract/lot (excluding VAT)
Total value of the contract/lot: 1.00 EUR
V.2.5)Information about subcontracting

Section VI: Complementary information

VI.3)Additional information:
VI.4)Procedures for review
VI.4.1)Review body
Official name: Vergabekammer bei der Finanzbehörde
Postal address: Große Bleichen 27
Town: Hamburg
Postal code: 20354
Country: Germany
E-mail: vergabekammer@fb.hamburg.de
Telephone: +49 40428231690
Fax: +49 40428232020
VI.5)Date of dispatch of this notice:
09/08/2022